Evaluation of alternative calculation methods for determining LDL cholesterol

Vnitrni Lekarstvi

Volumn 54, Issue 10, 2008, Pages 961-964

  Vohnout, Branislav ^a,b   Vachulova A ^a   Blazicek P ^c   Dukat A ^a   Fodor, G ^d   Lietava, J ^a  

^a Bratislava   (Slovakia)

^b CATHOLIC UNIVERSITY   (Italy)

^c Military Hospital   (Slovakia)

^d UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Alternative calculation formula; Friedewald formula; LDL C

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CALCULATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL;

ADULT; CHOLESTEROL, LDL; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; TRIGLYCERIDES;

EID: 55349104137     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Nauck M, Rifai N. Analytical performance and clinical efficacy of three routine procedures for LDL cholesterol measurement compared with the ultracentrifugation-dextran sulfate-Mg2+ method. Clin Chim Acta 2000; 294: 77-92.
2. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of the low-density lipoprotein cholesterol in plasma without the use of preparative ultra centrifugation. Clin Chem 1972; 18: 499-509.
3. Nauck M, Warnick GR, Rifai N. Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem 2002; 48: 236-254.
4. Planella T, Cortes M, Martinez-Bru C et al. Calculation of LDL-cholesterol by using apolipoprotein B for classification of non-chylomicronemic dyslipemia. Clin Chem 1997; 43: 808-815.
5. Hattori Y, Suzuki M, Tsushima M et al. Development of approximate formula for LDL-chol, LDL-apo B and LDL-chol/LDL-apo B as indices of hyperapobetalipoproteinemia and small dense LDL. Atherosclerosis 1998; 138: 289-299.
6. Sniderman AD, Furberg CD, Keech A et al. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 2003; 361: 777-780.
7. Bairaktari E, Elisaf M, Tzallas Ch et al. Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in hemodialysis patients. Clin Biochem 2001; 34: 593-602.
8. Bairaktari ET, Tzallas C, Kalientzidou M et al. Evaluation of alternative calculation methods for determining low-density lipoprotein cholesterol in hemodialysis patients. Clin Biochem 2004; 37: 937-940.
9. Bairaktari E, Hatzidimou K, Tzallas C et al. Estimation of LDL cholesterol based on the Friedewald formula and on apo B levels. Clin Biochem 2000; 33: 549-555.
10. Tremblay AJ, Morrissette H, Gagne JM et al. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin Biochem 2004; 7: 785-790.
11. Vachulová A, Vohnout B, Blažíček P et al. Vztcombining comma above rightah kalkulovaného LDL cholesterolu k hladinám apolipoproteínu B u subjektov s normálnymi a zvýšenými hladinami triacylglycerolov. Cardiol 2005; 14: 88-91.